BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 30896929)

  • 1. A Metal-Free DOTA-Conjugated
    Roxin Á; Zhang C; Huh S; Lepage M; Zhang Z; Lin KS; Bénard F; Perrin DM
    Bioconjug Chem; 2019 Apr; 30(4):1210-1219. PubMed ID: 30896929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evaluation of
    Roxin Á; Zhang C; Huh S; Lepage ML; Zhang Z; Lin KS; Bénard F; Perrin DM
    Nucl Med Biol; 2018 Jun; 61():11-20. PubMed ID: 29597141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.
    Beaino W; Anderson CJ
    J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma Imaging Using
    Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
    Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Al
    Gai Y; Yuan L; Sun L; Li H; Li M; Fang H; Altine B; Liu Q; Zhang Y; Zeng D; Lan X
    J Biol Inorg Chem; 2020 Feb; 25(1):99-108. PubMed ID: 31745667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
    Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F
    J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.
    Beaino W; Nedrow JR; Anderson CJ
    Mol Pharm; 2015 Jun; 12(6):1929-38. PubMed ID: 25919487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
    Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
    Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
    Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
    J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of an
    Nunes PSG; Zhang Z; Kuo HT; Zhang C; Rousseau J; Rousseau E; Lau J; Kwon D; Carvalho I; Bénard F; Lin KS
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):370-379. PubMed ID: 29247455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-AmBF3-MJ9: a novel radiofluorinated bombesin derivative for prostate cancer imaging.
    Pourghiasian M; Liu Z; Pan J; Zhang Z; Colpo N; Lin KS; Perrin DM; Bénard F
    Bioorg Med Chem; 2015 Apr; 23(7):1500-6. PubMed ID: 25757604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma.
    Choi J; Beaino W; Fecek RJ; Fabian KPL; Laymon CM; Kurland BF; Storkus WJ; Anderson CJ
    J Nucl Med; 2018 Dec; 59(12):1843-1849. PubMed ID: 29959213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography.
    Liu Z; Amouroux G; Zhang Z; Pan J; Hundal-Jabal N; Colpo N; Lau J; Perrin DM; Bénard F; Lin KS
    Mol Pharm; 2015 Mar; 12(3):974-82. PubMed ID: 25629412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Evaluation of New Bifunctional Chelators with Phosphonic Acid Arms for Gallium-68 Based PET Imaging in Melanoma.
    Gai Y; Sun L; Lan X; Zeng D; Xiang G; Ma X
    Bioconjug Chem; 2018 Oct; 29(10):3483-3494. PubMed ID: 30205001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging.
    Liu Z; Pourghiasian M; Bénard F; Pan J; Lin KS; Perrin DM
    J Nucl Med; 2014 Sep; 55(9):1499-505. PubMed ID: 24970911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of [
    Otaru S; Paulus A; Imlimthan S; Kuurne I; Virtanen H; Liljenbäck H; Tolvanen T; Auchynnikava T; Roivainen A; Helariutta K; Sarparanta M; Airaksinen AJ
    Bioconjug Chem; 2022 Jul; 33(7):1393-1404. PubMed ID: 35709482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
    Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
    J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents.
    Soodgupta D; Zhou H; Beaino W; Lu L; Rettig M; Snee M; Skeath J; DiPersio JF; Akers WJ; Laforest R; Anderson CJ; Tomasson MH; Shokeen M
    J Nucl Med; 2016 Apr; 57(4):640-5. PubMed ID: 26742713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.